Overview
IRIX market data
Price History
IRIX price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$0.26 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.68 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -6.2% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $0.80 – $1.65 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $15.1M · P/B 4.26 · P/S 0.29.
Company News
Iridex Expands Its EyeProGPO Product Offering To Include The Company’s Line Of EndoProbe HandpiecesBenzinga · Jul 20, 2026, 11:14 AM
8-K filing — IRIDEX CORP (IRIX)SEC EDGAR · Jul 16, 2026, 10:01 AM
Iridex Q1 2026 Earnings Call: Complete TranscriptBenzinga · May 19, 2026, 9:50 PM
Iridex Affirms FY2026 Sales Guidance of $51.000M-$53.000M vs $53.227M EstBenzinga · May 19, 2026, 8:20 PM
Iridex Q1 EPS $(0.03) Beats $(0.07) Estimate, Sales $11.799M Miss $11.910M EstimateBenzinga · May 19, 2026, 8:20 PM
Earnings Scheduled For May 19, 2026Benzinga · May 19, 2026, 11:15 AM